2018
DOI: 10.1002/mdc3.12597
|View full text |Cite
|
Sign up to set email alerts
|

Accuracy of Two Cognitive Screening Tools to Detect Mild Cognitive Impairment in Parkinson's Disease

Abstract: Background Patients with Parkinson's disease (PD) who have mild cognitive impairment (PD‐MCI) are at increased risk of developing PD dementia (PDD). Therefore, it is important to identify PD‐MCI in a reliable way. Objectives We evaluated the accuracy of the Parkinson's Disease‐Cognitive Rating Scale (PD‐CRS) and the Mattis Dementia Rating Scale‐2 (MDRS‐2) for detecting PD‐MCI. Data from healthy subjects were used to correct for demographic influences. Methods We compared the accuracy of the two instruments usi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
26
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(27 citation statements)
references
References 25 publications
(28 reference statements)
1
26
0
Order By: Relevance
“…We assessed the methodological quality of the included studies. We considered the case-control studies [ 29 , 57 , 61 ] to be at high risk of bias, as in diagnostic accuracy studies, the use of a case-control design increases both the sensitivity and specificity of the index test [ 53 ].…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…We assessed the methodological quality of the included studies. We considered the case-control studies [ 29 , 57 , 61 ] to be at high risk of bias, as in diagnostic accuracy studies, the use of a case-control design increases both the sensitivity and specificity of the index test [ 53 ].…”
Section: Resultsmentioning
confidence: 99%
“…The use of other sampling methods may lead to a high risk of introducing bias into the study [ 53 ]. Most of the studies did not report the method used to sample patients for inclusion [ 29 , 57 , 58 , 60 , 61 , 62 ]. A consecutive sample of PD patients was recruited in two studies [ 56 , 59 ].…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…To assess cognition, we used a general measure of global cognition, the Minimental State Exam (MMSE, Folstein, [28]), and a PD-specific measure, the Parkinson's Disease Cognitive Rating Scale (PD-CRS, [65]). The PD-CRS is a comprehensive cognitive rating battery specifically designed for PD, that can distinguish PD-MCI from PD with intact cognition [43], with validated cut-off scores for PD-MCI [45]. It comprises nine tasks, representing two sub-domains: (1) frontal subcortical tasks (sustained attention, working memory, alternating and action verbal fluency, clock drawing, immediate and delayed free recall verbal memory); and (2) posterior cortical tasks (confrontation naming and clock copying).…”
Section: Measures Of Clinical Variablesmentioning
confidence: 99%